ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

Fisher, interim NSABP Leadership Enter Third Day Of Negotiations To Settle Suit, Aver Court Battle

September 30, 1994

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012

Lineberger Endows Chair To Honor Denman Hammond.

April 13, 2001

Bill Would Harm Pancreatic Cancer Research – Scientists Warn Of Unintended Consequences

August 10, 2012

Panel To Take Up Issues In Grant/Peer Review System, Consider NCAB Membership Requirements

December 11, 1981

Cancer Center In Russia Seeks Cancer Drugs, Other Supplies, From US

July 30, 1993